drugset / Trial / NCT00849134

First Time in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Food of Single Assending Doses of GSK1482160.

NCT00849134 ↗

Phase 1 Completed 25 enrolled GlaxoSmithKline
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a first-time-in-human study. The overall purpose of the study is to assess whether the drug is safe and well tolerated after single, increasing doses. At different doses, we will look to see how much of the drug gets into the bloodstream, how the drug is broken down and excreted and whether this is affected by the presence of food.

Timeline

Start
2008-11-17
Primary completion
2009-04-06
Completion
2009-04-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator GSK1482160 Small molecule — —

Indications